It has been postulated that creation of Man 8 GlcNAc 2 isomer B (M8B) by endoplasmic reticulum (ER) ␣-mannosidase I constitutes a signal for driving irreparably misfolded glycoproteins to proteasomal degradation. Contrary to a previous report, we were able to detect in vivo (but not in vitro) an extremely feeble ER ␣-mannosidase activity in Schizosaccharomyces pombe. The enzyme yielded M8B on degradation of Man 9 GlcNAc 2 and was inhibited by kifunensin. Live S. pombe cells showed an extremely limited capacity to demannosylate Man 9 GlcNAc 2 present in misfolded glycoproteins even after a long residence in the ER. In addition, no preferential degradation of M8B-bearing species was detected. Nevertheless, disruption of the ␣-mannosidase encoding gene almost totally prevented degradation of a misfolded glycoprotein. This and other conflicting reports may be best explained by assuming that the role of ER mannosidase on glycoprotein degradation is independent of its enzymatic activity. The enzyme, behaving as a lectin binding polymannose glycans of varied structures, would belong together with its enzymatically inactive homologue Htm1p/ Mnl1p/EDEM, to a transport chain responsible for delivering irreparably misfolded glycoproteins to proteasomes. Kifunensin and 1-deoxymannojirimycin, being mannose homologues, would behave as inhibitors of the ER mannosidase or/and Htm1p/Mnl1p/EDEM putative lectin properties.
INTRODUCTION
Cells have to continuously monitor whether newly synthesized glycoproteins are in the process of proper folding or whether, alternatively, they are irreparably misfolded (Trombetta and Parodi, 2003) . Both folding intermediates and irreparably misfolded species may be retained in the endoplasmic reticulum (ER) as a consequence of their association with the ER unconventional chaperones calnexin (CNX) and calreticulin (CRT) (Parodi, 2000) . These lectins specifically recognize monoglucosylated N-glycans formed either by partial deglucosylation of the transferred glycan (removal of residues m and n from Glc 3 Man 9 GlcNAc 2 ; Figure 1) or by UDP-Glc:glycoprotein glucosyltransferase (GT)-mediated reglucosylation of the totally deglucosylated glycan (readdition of Glc l to Man g; Figure 1 ). However, as permanent residence of misfolded species in the ER has deleterious effects on cell viability, there are mechanisms for their recognition and subsequent diversion to degradation. It has been proposed that a particular glycan structure (Man 8 GlcNAc 2 isomer B or M8B; Figure 1 ) could be the signal by which cells recognize that a glycoprotein molecule is unable to reach its native three-dimensional structure (Knop et al., 1996; Jakob et al., 1998) . Because M8B is produced by ER mannosidase I, a slow-acting enzyme compared with the activity of ER processing glucosidases, it has been speculated that if a protein folds extremely slowly or if it is irreparably misfolded, it would display the particular M8B structure that in turn would be recognized by an ER lectin specific for that glycan and thus diverted to proteasomal degradation. Evidence for the involvement of ER mannosidase I in misfolded glycoprotein degradation was provided by several experimental observations, as for example, that ablation of the S. cerevisiae ER mannosidase encoding gene drastically reduced the rate of misfolded glycoprotein degradation and that the same effect resulted from addition of ER mannosidase I inhibitors (kifunensin, KFN or 1-deoxymannojirimycin, DMJ) to mammalian cells (for review, see Cabral et al., 2001 , and references therein). Concerning the postulated lectin, a presumably enzymatically ER mannosidase I homologue has been identified in S. cerevisiae (variously referred to as Htm1p or Mnl1p) and in mammalian cells (referred to as ER degradation enhancing ␣-mannosidase-like protein or EDEM) Jakob et al., 2001; Nakatsukasa et al., 2001) . Ablation of Htm1p/Mnl1p encoding gene in yeast or reduction of EDEM expression by the RNA interference technique in mammalian cells drastically reduced disposal of misfolded glycoproteins, whereas overexpression of EDEM increased the degradation rate Molinari et al., 2003; Oda et al., 2003) . Htm1p/Mnl1p/EDEM has not been isolated yet, so its putative lectin capacity has not been This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E05-03-0246) on August 3, 2005. confirmed. The human genome codes for two additional EDEM-like proteins. Characterization of the so called EDEM2 revealed that it displays no mannosidase activity and that its overexpression in mammalian cells enhances misfolded glycoprotein degradation (Mast et al., 2005; Olivari et al., 2005) . Both the Saccharomyces cerevisiae and Schizosaccharomyces pombe genomes code for only one Htm1p/ Mnl1p/EDEM protein. On the other hand, in S. cerevisiae there is an alternative, proteasome-independent pathway for ER-associated degradation (ERAD) (Umebayashi et al., 2001) .
The model by which N-glycan structural modifications introduced by ER ␣-mannosidase activity could play an essential role in driving irreparably misfolded glycoproteins to degradation is extremely attractive but presents several severe inconsistencies that will be discussed below in extenso. To further study the controversial role of ER mannosidase on ERAD of misfolded glycoproteins, we chose the fission yeast S. pombe because this yeast, contrary to S. cerevisiae, displays a quality control of glycoprotein folding similar to that present in mammalian cells. The fission yeast expresses a robust GT activity responsible for the glucosylation of folding intermediates and irreparably misfolded species (Fernández et al., 1994) . S. pombe GT is up-regulated under conditions of ER stress and ablation of its encoding gene triggers the so-called unfolded protein response (Fernández et al., 1996; D'Alessio et al., 1999) . In addition, GT was shown to be essential for cell viability under conditions of severe ER stress . What made S.
pombe a particularly interesting model system for the purpose of our work is that according to a previous report, no ER mannosidase activity could be detected in it, both in in vivo and in vitro assays (Ziegler et al., 1994) . Work here reported shows that this yeast displays indeed an extremely feeble ER mannosidase activity that could be detected in vivo but not in vitro. The extremely limited capacity to demannosylate Man 9 GlcNAc 2 glycans present in misfolded glycoproteins severely questions the accepted role of ER ␣-mannosidases on ERAD.
MATERIALS AND METHODS

Materials
[ 14 C]Glc (301 Ci/mol) was from PerkinElmer Life and Analytical Sciences (Boston, MA) . N-Methyldeoxynojirimycin (NMDNJ), KFN, and DMJ were from Toronto Biochemicals Toronto, Ontario, Canada. N-Carboxybenzoxylleucinyl-leucinyl-leucinal (MG132) and clasto-lactacystin-␤-lactone (lactacystin) were from Calbiochem (San Diego, CA). Restriction enzymes and other enzymes used in DNA procedures were from PerkinElmer Life and Analytical Sciences. Dithiothreitol (DTT) and endo-␤-N-acetylglucosaminidase H (Endo H) were from Sigma-Aldrich (St. Louis, MO).
Strains and Culture Media
The S. pombe strain was ADp (h ϩ , ade6, M216, . Growth medium contained 0.5% yeast extract (Difco, Detroit, MI), 3% glucose, and 75 mg/ml adenine. Minimal medium was as described previously (Alfa et al., 1993) . The S. cerevisiae strain used was HH3 (MAT␣, 
Labeling, Isolation, and Structural Analysis of N-Glycans
Cells were labeled and N-glycans isolated as described previously (Fernández et al., 1994) . Briefly, cells (0.3 g) were resuspended in 1 ml (total volume) of 1% yeast nitrogen base (YNB; Difco) to which 100 l of 50 mM Glc containing 150 Ci of [ 14 C]Glc was added. Incubation times were as described in text. Where indicated 100 l of 0.5 M Glc was added for chasing the label. KFN, DMJ, and NMDNJ (2.5 mM final concentrations) and lactacystin (50 M final concentration) were added 30 min and DTT (5 mM final concentration) 5 min before labeling. In experiments described in Figure 7 , A-C, cycloheximide (0.1 mg/ml final concentration) together with Glc (50 mM final concentration) were added 15 min after addition of the label and DTT concentration was raised to 10 mM after 35 min of chase. In experiment described in Figure 7D , DTT (5 mM final concentration) was added 70 min before the label and the drug concentration was raised to 10 mM 5 min before [ 14 C]Glc addition. Acetolysis and paper electrophoresis in 0.1 M sodium molybdate, pH 5.0, were as described previously (Engel and Parodi, 1985) . Chromatography was performed on Whatman no. 1 paper with solvents A, 1-propanol/nitromethane/water (5:2:4); B, 1-butanol/pyridine/water (4:3:4); C, 1-butanol/pyridine/water (10:3:3); and D, 2-propanol/acetic acid/water (29:4:9).
Gene Disruptions
Disruption of spmns1 ؉ . A 1390-base pair fragment of gene spmns1ϩ (gi: 6322591) was amplified using genomic DNA as template and primers 5Ј-TAACCGCGGATGGTTAAACGAAGGACTG-3Ј and 5Ј-CAACTCGAGCT-TCGACTCTACACTATC-3Ј and cloned in the pBluescript KSII(ϩ) vector. Fragment XbaI-BglII corresponding to bases 550 -816 was replaced with gene ura4 ϩ . A 2946-base pair fragment liberated with SacII and XhoI was used to transform S. pombe cells. Transformants were isolated in minimal medium supplemented with adenine and leucine. Correct integration was checked by Southern blotting analysis and by PCR with a primer from ura4 ϩ (5Ј-TTT-TCATCCCCTCAGCTC-3Ј) and from spmns1 ϩ (5Ј-TAACTCGAGCACCGTG-TACAGGTCC-3Ј). Disruption of spmns2 ϩ and spmnl1 ϩ . The same procedures were used for disruption of these genes, but in the first case amplification primers were 5Ј-GGACCTGCAGATGACACTCTTCCCAGTA-3Ј and 5Ј-CT-TCTCGAGGGCTCTCCAACTAGTTGG-3Ј (2985-base pair fragment) and in the second 5Ј-TATATACCGCGGATGGGTAGCTTGCACTC-3Ј and 5Ј-CAACTCGAGTTCACCATCCGTGATG-3Ј (2205 base pairs fragment). In the first case, a HindII fragment corresponding to bases 428-2324 and in the second a ClaI-XbaI fragment corresponding to bases 863-1600 was replaced with gene ura4 ϩ . In the first case, a 2946-base pair fragment liberated with PstI and XhoI and in the second a 3227-base pair fragment liberated with SacII and XhoI were used to transform S. pombe cells. Correct integration was checked Figure 1 . Glycan structures. The figure represents the glycan transferred to proteins in wild-type S. pombe cells (Glc 3 Man 9 GlcNAc 2 ). Lettering corresponds to the order of residue addition in the synthesis of the dolichol-P-P derivative. Numbers between monosaccharides correspond to the carbon atoms involved in the respective linkages. M8A lacks residues g and l-n, M8B residues j and l-n, and M8C residues k-n. The Man 7 GlcNAc 2 isomer formed in S. pombe lacks residues i and k-n. The glycan transferred in MadIA214cells (Man 5 GlcNAc 2 ) lacks residues h-n.
by Southern blotting analysis and by PCR using primers from ura4 ϩ 5Ј-TTT-TCATCCCCTCAGCTC-3Ј in the first case and 5Ј-TGCTCCTACAACAT-TACC-3Ј in the second and primers from spmns2 ϩ 5Ј-TAACTCGAGCACCGT-GTACAGGTCC-3Ј and from spmnl1 ϩ 5Ј-TTGACGCACAGAGACGTTG-3Ј.
Sequence Analysis
The program used for calculating similarities between sequences was the Water from the European Bioinformatics Institute (www.ebi.ac.uk) using BLOSUM62 as matrix.
In Vitro ␣-Mannosidase Assays S. cerevisiae and S. pombe microsomes were prepared as described previously (Fernández et al., 1994) . One milligram of microsomal proteins was incubated with 7000 cpm of [ 14 C-Man]Man 9 GlcNAc in 50 mM PIPES buffer, pH 7.1, 1 mM CaCl 2 and 0.4% Lubrol in a total volume of 100 l. After 30 min at room temperature, 200 ml of methanol was added, tubes were centrifuged at low speed, and supernatants were spotted on Whatman no. 1 paper. Chromatograms were developed with solvent D.
S. cerevisiae CPY* Expression in S. pombe S. cerevisiae gene encoding for caboxypeptidase Y (CPY) was amplified using Pfu polymerase, genomic DNA as template and primers 5Ј-CGTCTCGAGAT-GAAAGCATTCACC-3Ј and 5Ј-ATACCCGGGTTATAAGGAGAAACCAC-CGTG-3Ј and cloned in vector pBluescript KS II (ϩ). Base 763 was mutated (G to A) by PCR with primers 5Ј-CATCGCTAGGGAATCCTAC-3Ј and 5Ј-TG-GAAATCTTGGCCCTTG-3Ј. The product (encoding CPY*) was sequenced to check the mutation introduced and cloned in sites XhoI and SmaI of S. pombe expression vector pREP3X, which was used to transform wild-type and mutant S. pombe strains as described previously .
CPY* degradation in S. pombe
Cells expressing S. cerevisiae CPY* were grown in SC medium (0.67% YNB [Difco], 2% Glc, and 70 mg/ml adenine and uracyl) at 28°C up to an OD 600 of 0.2-0.3. About 15 OD 600 of cells was withdrawn, centrifuged, and resuspended in 0.6 ml of SC medium but without Met (YNB without amino acids; Difco). Cells were incubated for 30 min, and 300 Ci of EasyTaq Express Labeling Mix (PerkinElmer Life and Analytical Sciences) was added. Where indicated, KFN, DMJ, lactacystin, and MG132 (final concentrations, 2.5 mM the first two drugs and 50 M the last two) were added 30 min before the label. Cycloheximide (1 mM final concentration) was added 15 min after the label, and 200-l aliquots were withdrawn 0 and 30 min after addition of the protein synthesis inhibitor. Two hundred milliliters of 2ϫ stop buffer (2 M sorbitol, 50 mM Tris-HCl, pH 7.5, 40 mM NaN 3 , and 20 mM DTT) was added to the samples, which were then frozen to -70°C until extract preparation. For this purpose 5 l of lysing enzymes (10 mg/ml) was added, and samples were incubated for 25 min at 30°C. Trichloroacetic acid (5% final concentration) was added and samples were maintained on ice for 30 min. Samples were then centrifuged, and pellets were washed with ice-cold acetone. Pellets were resuspended in 100 l of boiling buffer (50 mM Tris-HCl, pH 7.5, 1 mM EDTA, and 1% SDS). Resuspended samples were sonicated, stirred in a Vortex with glass beads and boiled for 4 min. Immunoprecipitation buffer (1 ml of 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% Tween 20, and 0.1 mM EDTA) was then added. The extracts were centrifuged and to supernatants CPY antiserum was added. Samples were then incubated overnight at 4°C with gentle stirring. Protein A-Sepharose was then added, samples were incubated for 3 h and then centrifuged at low speed. Supernatants were withdrawn and CNX antiserum was added to them. Pellets of the anti-CPY immunoprecipitations were washed first with immunoprecipitation buffer and then with the same solution but containing in addition 2 M urea, 0.1% SDS, and finally with Tris buffer saline. Pellets were then heated at 100°C for 5 min with 2ϫ sample buffer (125 mM Tris-HCl, pH 6.8, 20% glycerol, 10% ␤-mercaptoethanol, and 6% SDS). Supernatants were run on SDS-PAGE, dried, and CPY* quantified with a PhosphoImager. Immunoprecipitations with CNX antiserum were likewise performed. Amounts of CNX occurring under different conditions were used to normalize recovery of CPY* in the samples.
RESULTS
S. pombe Expresses an ␣-Mannosidase
As mentioned above, a previous report indicated that S. pombe cells do not express an ER mannosidase (Ziegler et al., 1994) . Nevertheless, incubation of live wild-type S. pombe cells with 5 mM radioactive Glc for 15 min led to formation of Endo H-released protein-linked Man 9 GlcNAc and Man 8 GlcNAc. The proportion of the smaller compound ranged between 5 and 8% ( Figure 2A ). Practically no larger glycans were observed after a 15-min incubation but Golgi elongation of above-mentioned N-glycans was observed on chasing cells with a 10-fold higher unlabeled Glc concentration ( Figure 2B ). Man 8 GlcNAc 2 was also formed when cells were labeled at 50 mM Glc concentration.
Identification of the ␣-Mannosidase Encoding Gene
There are three proteins encoded in the S. pombe genome with potential ␣-mannosidase activity: Spmns1p (gi48474992), Spmns2p (gi:19114891) , and Spmnl1p (gi:19115346) (Sp stands for S. pombe). They, respectively, show higher similarity to S. cerevisiae ER ␣-mannosidase (56.8%), to vacuolar mannosidase (65.1%), and to the mannosidase-like protein (otherwise referred to as Htm1p/ Mnl1p/EDEM) (45.0%).
Their encoding genes were individually disrupted and resulting mutants assayed for formation of protein-linked glycans. Only the mutant lacking Spmns1p showed no formation of Man 8 GlcNAc 2 (Figure 3, A-D) . Transcription of the Htm1p/Mnl1p/EDEM-encoding gene (spmnl1 ϩ ) in wild-type cells was confirmed by reverse transcription-PCR.
Structural Characterization of Man 8 GlcNAc 2
Man 8 GlcNAc was submitted to acetolysis, a procedure that preferentially cleaves ␣(1,6) bonds between Man units, and resulting fragments were separated on paper chromatogra- phy. Labeled compounds migrated as Man 4 GlcNAc and Man 2 standards ( Figure 4A ). Reduction of the latter followed by paper electrophoresis in sodium molybdate, pH 5.0, revealed that about half of the label remained at the origin, whereas the rest migrated to the anode ( Figure 4B ). As ␣(1,2)-linked reduced Man 2 migrates under the assay conditions, whereas the ␣(1,3)-linked isomer does not, results obtained indicate that Man 8 GlcNAc 2 isomer B (M8B) was produced by S. pombe Spmns1p mannosidase (Figure 1 ) (Parodi et al., 1983) . A mixture of M8B and M8C isomers (Figure 1 ) was obtained if the Glc concentration during the labeling period of wild-type cells was reduced to 0.5 mM.
On the other hand, the Spmns1p minus mutant only yielded M8C under similar labeling conditions. Because M8C but not M8B is an intermediate in the synthesis of dolichol derivatives, these results indicate that under low Glc concentrations, S. pombe cells, the same as the mammalian cells, synthesize and transfer to proteins a sizable proportion of incomplete glycans (Gershman and Robbins, 1981; Rearick et al., 1981) .
The Effect of ␣-Mannosidase
Inhibitors KFN and DMJ were tested as potential Spmns1p inhibitors. Wild-type cells were preincubated with the compounds at a 2.5 mM concentration for 30 min before addition of labeled glucose. As depicted in Figure 5 , A-C, whereas KFN significantly inhibited M8B formation, absolutely no effect was observed upon addition of DMJ. No inhibition was observed also when 2.5 mM DMJ was tested under similar in vivo conditions as S. cerevisiae ER ␣-mannosidase inhibitor. Because the DMJ concentration used is 50-fold higher than the IC 50 of the drug for the last enzyme as determined in cell free assays (Jelinek-Kelly et al., 1985) , this indicates that penetration of DMJ into the budding yeast ER, and probably also into that of S. pombe, is severely impeded.
Subcellular Localization of Spmns1p
Wild-type cells were incubated with 5 mM labeled glucose for 15 min in the presence of DTT. This compound effectively prevents proper folding, and thus ER exit, of glycoproteins by interfering with disulfide bond formation (Simons et al., 1995) . Secretion of disulfide-free proteins is not affected, but as already reported and as will be further shown below, the majority of glycoproteins synthesized in S. pombe have disulfide bonds (Fernández et al., 1998) . M8B was still formed under the experimental conditions used, thus indicating that Spmns1p localized to the ER ( Figure 6A ). To confirm the subcellular localization of S. pombe ␣-mannosidase, we took advantage of the presence of GT in this yeast ER: an alg6 mutant was incubated for 15 min with labeled glucose in the presence of 5 mM DTT and 2.5 mM NMDNJ, a glucosidase II inhibitor. In alg6 mutants, Man 9 GlcNAc 2 instead of Glc 3 Man 9 GlcNAc 2 is transferred to proteins because they lack the enzyme that transfers the first Glc residue from Glc-P-dolichol to Man 9 GlcNAc 2 -P-P-dolichol. Compounds migrating in the positions expected for Glc 1 Man 9 GlcNAc, Man 9 GlcNAc, and Glc 1 Man 8 GlcNAc were formed ( Figure 6B ). Rather surprisingly, no Man 8 GlcNAc occurred in the chromatogram. Compounds migrating as Glc 1 Man 9 GlcNAc, Man 9 GlcNAc and Glc 1 Man 8 GlcNAc were individually rerun on paper chromatography to get a better separation and submitted then to strong acid hydrolysis followed by monosaccharide separation by paper chromatography. As shown in Figure 6 , C-E, compounds migrating as Glc 1 Man 9 GlcNAc and Glc 1 Man 8 GlcNAc contained labeled Glc and Man units, whereas that migrating as Man 9 GlcNAc only contained the last residues. Formation of Glc 1 Man 8 GlcNAc 2 indicated that S. pombe ␣-mannosidase (Spmns1p) and GT shared the same subcellular compartment. Figure 2 , A and B, shows that a minimal proportion of N-glycans was processed to Man 8 GlcNAc 2 under normal folding conditions. To study ER processing of N-glycans present in misfolded species, S. pombe cells were incubated with 5 mM [ 14 C]Glc for 15 min in the presence of DTT and lactacystin to prevent protein folding and degradation, respectively. Contrary to what happens in S. cerevisiae, S. pombe wild-type cells are freely permeable to the proteasome inhibitor. Cells were then chased with 50 mM Glc, and 0.15 mg/ml cycloheximide was added to hinder further protein synthesis and thus N-glycosylation. Samples were withdrawn 0, 15, 45, and 90 min after the chase. The pattern of the N-glycans of the 0-min chase sample was similar to that shown in Figure 2A , whether incubation had been performed in the presence or absence of DTT. The sample obtained after 45-min chase in presence of the drug showed little if any Golgi elongation of N-glycans ( Figure 7A ) and the presence of both Man 8 GlcNAc and Man 7 GlcNAc in addition to Man 9 GlcNAc. No Man 6 GlcNAc was detected. The pattern yielded by cells pulse chased in the absence of DTT revealed a normal Golgi processing of glycans ( Figure 7B ). This showed that DTT had effectively prevented ER exit of most glycoproteins. The relative proportions of Man 9 GlcNAc, Man 8 GlcNAc, and Man 7 GlcNAc in the samples are represented in Figure 7C . It may be observed that the rate of Man 9 GlcNAc 2 processing gradually decreased and finally completely ceased although, as shown in Figure  7 , A and B, glycoproteins were still in the ER after the 45-min chase as they did not show a significant Golgi processing. Moreover, DTT inactivation of ER ␣-mannosidase was ruled out by preincubating cells for 70 min in the presence of the pombe wild-type cells were incubated for 15 min with 5 mM labeled Glc, and whole cell Endo H-released glycans were run on paper chromatography with solvent A. DTT (5 mM final concentration) was added 5 min before the label. (B) S. pombe alg6 mutant were preincubated with 2.5 mM NMDNJ for 30 min and 5 mM DTT for 5 min and incubated for 15 min with 5 mM labeled Glc. Whole cell Endo H-released glycans were run on paper chromatography with solvent A. Material running between 27 and 29 cm (Glc 1 Man 9 GlcNAc), 31 and 32 cm (Man 9 GlcNAc), and 33 and 35 (Glc 1 Man 8 GlcNAc) in B was eluted and run for a second time on paper chromatography with solvent A. Material running as Glc 1 Man 9 GlcNAc (C), as Man 9 GlcNAc (D), and as Glc 1 Man 8 GlcNAc (E) was submitted to strong acid hydrolysis (1 N HCl for 4 h at 100°C) and run on paper chromatography with solvent C. Standards: 1-9, Glc 1 Man 9 GlcNAc; 9, Man 9 GlcNAc; 1-8, Glc 1 Man 8 GlcNAc; 8, Man 8 GlcNAc; 2, Glc; and 1, Man. For further details, see Materials and Methods. drug followed by a 15-min pulse with [ 14 C]Glc ( Figure 7D ). The most plausible explanation for results shown in Figure  7C is that misfolded glycoproteins had migrated to an ER domain lacking ␣-mannosidase activity. Cells pulsed chased in the presence or absence of lactacystin yielded almost identical proportions of Man 9 GlcNAc 2 , Man 8 GlcNAc 2 , and Man 7 GlcNAc 2 after the 90-min chase ( Figure 7C ). Because lactacystin but not DTT hindered proteasomal degradation and substantial degradation of glycoproteins unable to properly fold is expected to had occurred in the absence of the former drug after a 90-min chase (see below), this result indicates that no preferential degradation of misfolded glycoprotein-linked M8B over Man 9 GlcNAc 2 or Man 7 GlcNAc 2 had occurred.
Glycan Processing in Misfolded Glycoproteins
Structural characterization of Man 7 GlcNAc was performed as described above for Man 8 GlcNAc. Acetolysis of Man 7 GlcNAc yielded Man 4 GlcNAc 2 , Man 2 , and Man (Figure 4C) . Further reduction of the disaccharide followed by paper electrophoresis in 0.1 M sodium molybdate, pH 5.0, revealed that the compound was Man␣(1,3)Man ( Figure  4D ). The structure of Man 7 GlcNAc is depicted in Figure 1 . S. pombe ER ␣-mannosidase seemed to have, therefore, the same specificity as the S. cerevisiae enzyme (Herscovics et al., 2002) . From results here presented it may be concluded that although the fission yeast had an extremely limited capacity to demannosylate N-glycans in misfolded glycoproteins, both M8B and Man 7 GlcNAc 2 were produced on ER processing of glycans. Moreover, even this last compound, which was the smallest yielded by ER processing, displayed the acceptor Man unit involved in GT-mediated reglucosylation (residue g, Figure 1 ).
In Vitro Assay of S. pombe ER ␣-Mannosidase:
Comparison with S. cerevisiae S. pombe and S. cerevisiae microsomal membranes were incubated with [ 14 C-Man]Man 9 GlcNAc under identical conditions, the reactions stopped with 66% methanol, and the supernatants run on paper chromatography. Only S. cerevisiae microsomes produced Man ( Figure 8A ). Although the proportion of label in the monosaccharide (ϳ12%) indicated that the reaction had reached completion in the case of the budding yeast, absolutely no labeled monosaccharide was produced by S. pombe microsomes. Mixed membrane experiments discarded the presence of an inhibitor or a strong protease in the fission yeast microsomes. Moreover, the same result was obtained when a strong antiproteolytic cocktail was used for S. pombe microsome preparation. A previous report also communicated that in vitro assays had failed to detect S. pombe ER ␣-mannosidase (Ziegler et al., 1994) . To further compare S. cerevisiae and S. pombe ER ␣-mannosidase activities, we incubated the former cells with labeled [
14 C]Glc under conditions identical to those described in Figure 2A for the latter cells, but for 5 min instead of 15 min. As depicted in Figure 8B , the pattern of N-glycans was composed of ϳ80% Man 8 GlcNAc and almost equal proportions of Man 9 GlcNAc and Man 7 GlcNAc. S. cerevisiae had, therefore, at least more than one order of magnitude higher capacity than S. pombe to process N-linked Man 9 GlcNAc 2 .
CPY* Degradation in S. pombe
The extremely feeble ER ␣-mannosidase activity present in S. pombe, that even after 90 min could not degrade Ͼ35% of Man 9 GlcNAc 2 present in misfolded glycoproteins, suggested that the enzyme might not be related to ERAD in the fission yeast. To test this possibility, we expressed in S. pombe a mutant of S. cerevisiae carboxypeptidase Y unable to properly fold (CPY*). Cells were pulsed for 30 min with [ 35 S]MetϩCys and chased. CPY* degradation was followed by immunoprecipitation, SDS-PAGE, and autoradiography. As depicted in Figure 9 , ϳ61% of CPY* had disappeared from wild-type cells after a 30-min chase. A similar value has been reported for degradation of the same glycoprotein in S. cerevisiae after the same chase period (Jakob et al., 1998) . A sharply decreased degradation was observed when CPY* was expressed in Spmns1p or Spmnl1p minus mutants, the same as has been described for S. cerevisiae (Figure 9 ). These results showed that indeed the presence of ER ␣-mannosidase and of the ␣-mannosidase-like protein (Htm1p/ Mnl1p/EDEM) was fundamental for misfolded glycoprotein degradation also in S. pombe. CPY* degradation was totally or almost totally prevented in the presence of KFN, an effective ER ␣-mannosidase inhibitor, or of the proteasomal inhibitors lactacystin or MG132 (Figure 9 ). Neither DMJ nor DTT modified the extent of degradation of CPY* expressed in wild-type cells. The lack of effect of the former drug was expected, because it did not inhibit in vivo Spmns1p activity, probably because an impediment in the penetration into the ER lumen ( Figure 5C ).
DISCUSSION
Here, we show that, contrary to a previous report (Ziegler et al., 1994) , S. pombe displays an ␣-mannosidase that localizes to the ER and we have identified its encoding gene. The enzyme seemed to be inhibited by KFN and to display the same specificity as its homologue from S. cerevisiae because it also produced first M8B and then the same Man 7 GlcNAc 2 isomer upon Man 9 GlcNAc degradation.
The most remarkable feature of S. pombe ER ␣-mannosidase is the feeble activity that it displays in vivo and our and others inability to detect its activity in in vitro assays (Ziegler et al., 1994) . Triggering misfolding of newly synthesized glycoproteins by DTT addition resulted in hindering their exit from the ER and in a limited conversion of Man 9 GlcNAc 2 to M8B and Man 7 GlcNAc 2 . After an initial burst of Man 9 GlcNAc 2 degradation, all activity on misfolded glycoproteins ceased probably due to migration of the latter to ER domains lacking ␣-mannosidase. This result suggests that M8B might not be a signal for diversion of misfolded glycoproteins to degradation in S. pombe. Although in this yeast, the same as in other cells, the proportion of misfolded glycoproteins that are degraded through the glycan-and proteasome-dependent and proteasome-independent ERAD pathways is unknown, it should be expected that even if the former represented a minor pathway compared with the independent pathway, degradation of Man 9 GlcNAc 2 linked to misfolded glycoproteins to Man 8 GlcNAc 2 should have been fully completed after 90 min and not stopped at a 35% level after 45 min. An exclusive demannosylation of glycoproteins following the dependent pathway (i.e., bearing the 35% of glycans degraded) is highly unlikely because no ER mannosidase able to distinguish between glycoproteins that follow the alternative degradation pathways has been described so far. In fact, all ER ␣-mannosidases characterized already have been shown not to sense the conformational or soluble or membrane-bound status of the protein moieties. Exactly the same proportion of Man 9 GlcNAc 2 , M8B, and Man 7 GlcNAc 2 glycans was produced under conditions allowing or not glycoprotein proteasomal degradation. These results also suggest that M8B might not be a signal for diverting misfolded glycoproteins to degradation, although this conclusion is valid only if the glycan-and proteasome-dependent ERAD pathway represents a relatively major pathway. S. pombe had a much lower capacity to process Man 9 GlcNAc than S. cerevisiae: in vitro assays in which all the labeled glycan had been converted to M8B with microsomes prepared from the budding yeast failed to release any detectable radioactivity when S. pombe membranes were used. Moreover, Ͼ90% of Man 9 GlcNAc 2 had been processed to M8B and Man 7 GlcNAc 2 after a 5-min incubation of S. cerevisiae cells with labeled glucose, whereas a 15-min incubation of S. pombe cells only showed 5-8% of glycan conversion. It is unknown for the moment whether the extremely low ␣-mannosidase activity observed in S. pombe is a consequence of low levels of enzyme expression, or, alternatively, of an intrinsically poor activity of the protein. It is possible that our and others inability to detect its activity in cell free assays could be a consequence of a significantly high K m value for the substrate used (Man 9 GlcNAc).
It may be speculated that the sharp differences observed between S. pombe and S. cerevisiae capacities for Man 9 GlcNAc 2 processing might reflect the absence of a glycan-and proteasome-dependent ERAD pathway in the former yeast. This happened not to be the case because S. cerevisiae CPY* expressed in wild-type S. pombe cells was degraded to the same extent as in the budding yeast after a 30-min period (Jakob et al., 1998) . Ablation of genes coding for ␣-mannosidase or for the mannosidase-like protein (Htm1p/Mnl1p/EDEM) (spmns1 ϩ or spmnl1 ϩ genes, respectively) resulted, the same as in S. cerevisiae, in a drastic reduction in CPY* degradation. This last process was also hindered upon addition of the ␣-mannosidase inhibitor KFN or of proteasome inhibitors lactacystin and MG132 but not of DMJ or DTT. The differential effects of KFN and DMJ agree with their differential capacities to inhibit in vivo Spmns1p activity. As mentioned above, penetration of DMJ into S. pombe ER is probably severely hindered. DMJ at 1 mM concentration, that is, a concentration 50-fold higher than the IC 50 of the drug for the mammalian cell ER ␣-mannosidase I, effectively delayed misfolded glycoprotein degradation in those cells (Tremblay and Herscovics, 1999; Tokunaga et al., 2000; Wilson et al., 2000) . This strongly suggests a facilitated penetration of DMJ into the mammalian cell ER lumen.
It is evident that M8B cannot be per se a signal for diverting misfolded glycoproteins to proteasomal degradation in S. cerevisiae. Although it is by far the main glycan produced in the ER in this yeast, all glycans transferred to newly synthesized polypeptide chains are converted to it in the ER in all glycoproteins, even in those that fold properly (Byrd et al., 1982) . That is, no discrimination between properly folded, irreparably misfolded, and folding intermediates can be made by cells based solely on the presence of M8B. Moreover, according to results shown in Figure 8B , demannosylation of Man 9 GlcNAc 2 presumably occurs immediately after glycan transfer, before glycoproteins complete their folding attempts, that is, before cells have to decide whether to derive glycoproteins to the Golgi or to proteasomes. M8B is the glycan present in S. cerevisiae ER ␣-mannosidase, an ER-permanent resident protein (Vallée et al., 2000b) , thus indicating that glycoproteins bearing that glycan are not necessarily bound to degradation. 35 S]MetϩCys. Protein synthesis was stopped upon addition of cycloheximide, and aliquots were withdrawn 0 and 30 min after addition of the protein synthesis inhibitor. Cells were lysed and CPY* immunoprecipitated, run on SDS-PAGE, and submitted to autoradiography. KFN, DMJ, lactacystin, and MG132 (final concentrations: 2.5 mM the first two drugs and 50 M the last two drugs) were added 30 min and DTT (5 mM) 5 min before the label. Recovery of CPY* in immunoprecipitates was normalized by quantification of immunoprecipitated CNX from the same extracts.
The role of M8B as a signal for protein degradation is even more controversial in mammalian cells. As mentioned above, the main evidence for such a role comes from the observation that ␣-mannosidase inhibitors such as KFN or DMJ also inhibited misfolded glycoprotein degradation (Liu et al., 1997; De Virgilio et al., 1999; Chung et al., 2000; Marcus and Perlmutter, 2000; Fagioli and Sitia, 2001) . Contrary to what happens in both S. cerevisiae and S. pombe, where there is a single ␣-mannosidase in the ER and none in the Golgi, two such activities, referred to as I and II, that produce M8B and Man 8 GlcNAc 2 isomer C (M8C, Figure 1) , respectively, have been described in the mammalian cell ER (Weng and Spiro, 1993; González et al., 1999; Tremblay et al., 1999) . In addition, three other ␣-mannosidases localize to the cisGolgi (referred to as IA, IB, and IC). These three ␣-mannosidases are able to degrade Man 9 GlcNAc 2 to Man 5 GlcNAc 2 and are inhibited by both KFN and DMJ. Two of them (IA and IC) yield M8A as first degradation product, whereas IB yields both M8A and M8C (Figure 1) (Lal et al., 1998; Tremblay and Herscovics, 2000) . The activities of cis-Golgi mannosidases are noteworthy because misfolded glycoproteins may cycle between the Golgi and the ER before being diverted to proteasomes (Caldwell et al., 2001; Sato et al., 2001) . In addition, an endomannosidase (not inhibited by KFN or DMJ) present in both the cis Golgi and in the ER-Golgi intermediate compartment (ERGIC) may degrade Glc 1 Man 9 GlcNAc 2 (the GT reaction product) to M8A (Zuber et al., 2000) . M8A is unable to be reglucosylated by GT because it lacks Man residue g (Figure 1 ). Because GT, CNX, and CRT have been described to localize not only to the ER but also to the ERGIC (Zuber et al., 2001) , endomannosidase degradation of misfolded glycoproteins may trigger their release from the lectin anchors, thus driving them to proteasomal degradation.
The variety of ␣-mannosidases present in the mammalian cell ER and cis-Golgi may explain, for example, that the single N-glycan present in 3-hydroxy-3-methylglutaryl-CoA reductase, an ER resident membrane glycoprotein, presents the so-called microheterogeneity because Man 8 GlcNAc 2 , Man 7 GlcNAc 2 , Man 6 GlcNAc 2 , and Man 5 GlcNAc 2 glycans were detected in the enzyme. M8B and a single Man 6 GlcNAc 2 isomer were the main species (32 and 43%, respectively) (Bischoff et al., 1986) . This result confirms that glycoproteins residing in the mammalian cell ER for long periods, as misfolded species do, may have substantial amounts of glycans different from M8B and that those displaying such glycans are not necessarily bound for degradation. Furthermore, it has been determined that glycans in glycoproteins subject to ERAD are processed to Man 6 GlcNAc 2 and Man 5 GlcNAc 2 (Frenkel et al., 2003) . Additional observations also cast doubts on the role of M8B as a signal for misfolded glycoprotein degradation in mammalian cells. For example, it was reported that KFN and DMJ delayed proteasomal degradation of a short-lived soluble ribophorin I variant expressed in MadIA214 cells (Ermonval et al., 2001) . These cells transfer to proteins Man 5 GlcNAc 2 instead of Glc 3 Man 9 GlcNAc 2 ( Figure 1) ; thus, no M8B can be formed in them. It was also reported that addition of KFN and/or DMJ delayed degradation of misfolded glycoproteins synthesized in the presence of glucosidase I and II inhibitors (deoxynojirimycin and castanospermine) (Tokunaga et al., 2000; Wilson et al., 2000) . Because these compounds prevent removal of glucose units from transferred glycans, no M8B can be formed under the experimental conditions used.
An alternative explanation provided for the role of mannosidases in irreparably misfolded glycoprotein disposal assumes that, as the extensive glycan processing observed in misfolded glycoproteins (formation of Man 6 GlcNAc 2 and Man 5 GlcNAc 2 ) removes the residue to which GT adds the Glc unit (residue g, Figure 1 ), ensuing liberation of misfolded glycoproteins from their CNX/CRT anchors would allow their diversion to proteasomes (Frenkel et al., 2003) . It was recently reported that both S. cerevisiae and mammalian ER ␣-mannosidases I are not as specific as initially thought because they are able to further degrade M8B (Herscovics et al., 2002) . It was also suggested that the enhanced misfolded glycoprotein degradation observed upon overexpression of mammalian ER mannosidase I in mammalian cells could be a consequence of arresting GT-mediated reglucosylation . This alternative explanation is not applicable to S. cerevisiae, a yeast lacking GT, or to S. pombe, because the smallest glycan produced in this yeast (Man 7 GlcNAc 2 , Figure 1 ) still conserved residue g. Furthermore, the above-mentioned reports according to which KFN/DMJ inhibited degradation of misfolded glycoproteins synthesized in the presence of glucosidase inhibitors argue against this alternative explanation: as residues l-n (Figure 1 ) block ER ␣-mannosidase-mediated removal of residue g, no effect of KFN/DMJ addition should had been observed.
All reports on this issue, including the present report, may be best explained by assuming that the effect of ER mannosidase I on misfolded glycoprotein degradation is independent of its enzymatic activity, that is, that ER mannosidase I behaves as a lectin binding polymannose glycans of varied structures, and belongs, together with its enzymatically inactive homologue Htm1p/Mnl1p/EDEM, to a transport chain responsible for delivering misfolded glycoproteins to proteasomes. The crystal structure of S. cerevisiae ER ␣-mannosidase revealed that the enzyme catalytic cavity interacted with the glycan of an adjacent enzyme molecule (Vallée et al., 2000b) . In addition, evidence was presented indicating that KFN and DMJ occupy the same cavity (Vallée et al., 2000a) . The observed effects of KFN and DMJ on misfolded glycoprotein disposal could be due not to their activities as ER mannosidase inhibitors but, because they are Man homologues, to inhibition of the ER mannosidase or/and Htm1p/Mnl1p/EDEM putative lectin properties. Furthermore, the above-mentioned presence of a variety of different N-glycan structures in irreparably misfolded glycoproteins, the degradation of which is inhibited by KFN/DMJ, point not to a restricted but rather to a broad specificity of the putative ER lectins (both ␣-mannosidase I and Htm1p/ Mnl1p/EDEM) involved in glycoprotein degradation.
